Trafermin

N/A

Report date: 2024/11/20 09:57:23

Base Information

Drug NameTrafermin
Drug Alias Name曲夫明trafermine曲弗明bFGFFGF-2 +[16] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsPressure UlcerSkin UlcerDiabetic Foot +[6] 
Global Approved IndicationsPressure UlcerSkin UlcerPeriodontitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2001/04/04
Country/TerritoryCzechiaBelgiumBulgaria +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKaken Pharmaceutical Co Ltd
Inactive CompaniesOlympus Biotech Co
Active IndicationsPressure UlcerSkin UlcerPeriodontitis
Inactive IndicationsDiabetic FootPeriodontal Attachment LossAlveolar Bone Loss

Other Information

ATC CodeD03
Related LinksKEGG